Addex Therapeutics Ltd. (ADXN) Current Assets (2022 - 2024)

Addex Therapeutics' Current Assets history spans 3 years, with the latest figure at $4.0 million for Q4 2024.

  • For Q4 2024, Current Assets fell 15.32% year-over-year to $4.0 million; the TTM value through Dec 2024 reached $4.0 million, down 15.32%, while the annual FY2024 figure was $4.0 million, 14.62% down from the prior year.
  • Current Assets for Q4 2024 was $4.0 million at Addex Therapeutics, down from $4.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $8.1 million in Q4 2022 and bottomed at $4.0 million in Q4 2024.
  • The 3-year median for Current Assets is $4.8 million (2023), against an average of $5.6 million.
  • The largest annual shift saw Current Assets crashed 41.26% in 2023 before it fell 15.32% in 2024.
  • A 3-year view of Current Assets shows it stood at $8.1 million in 2022, then plummeted by 41.26% to $4.8 million in 2023, then decreased by 15.32% to $4.0 million in 2024.
  • Per Business Quant, the three most recent readings for ADXN's Current Assets are $4.0 million (Q4 2024), $4.8 million (Q4 2023), and $8.1 million (Q4 2022).